Search results
Merck and Bristol-Myers Squibb are bracing to lose their most lucrative patents this decade
Quartz· 44 minutes agoPharma giants Merck and Bristol-Myers Squibb are both getting ready for some of their key drug...
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 16 minutes agoMerck stock popped Thursday after the Dow Jones stalwart topped Wall Street's first-quarter views on...
Merck shares target raised on strong Q1 performance By Investing.com
Investing.com· 48 minutes agoOn Thursday, Truist Securities adjusted the stock price target for Merck (NYSE:MRK), a global...
Merck (MRK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 48 minutes agoImage source: The Motley Fool. Merck (NYSE: MRK) Q1 2024 Earnings Call Apr 25, 2024, 9:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call...
Merck stock gains on Q1 2024 beat (NYSE:MRK)
Seeking Alpha· 9 hours agoMerck (MRK) stock gains as the company posts better than expected Q1 2024 financials with strong sales growth from its cancer medicine Keytruda. Read...
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 2 hours agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 10 hours agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda
Reuters via AOL· 10 hours ago(Reuters) -Merck & Co on Thursday raised its annual profit and revenue forecast on the back of...
Merck Raises Forecast as Sales of Its Cancer Immune Therapy Soar
Bloomberg· 10 hours agoMerck & Co. raised its annual profit and revenue forecast as the blockbuster cancer drug Keytruda...
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 10 hours agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...
